Boston Scientific’s AI leadership, global growth, and strong R&D make it a long-term winner despite valuation and regulatory ...

Abbott’s Q2 showed resilience amid macro risks, with its dividend strength and fair valuation reinforcing long-term appeal.

Read about how to grow resilient passive income with a balanced dividend growth strategy, focusing on quality, stability, and ...

APA Corp. is generating strong cash flow, reducing debt. APA stock offers a 5.5% dividend yield, making it a compelling ...

Visa upgraded to 'Buy' for strong financials, evolving B2B focus, exceptional profitability, and reliable growth, despite ...

Arbor Realty’s dividend cut and weak coverage keep me neutral on common shares, despite strong origination and NPL ...

Jussi Askola is the President of Leonberg Capital, a value-oriented investment boutique that consults hedge funds, family ...

Gulfport trimmed 2025 output guidance after midstream issues but shows solid well results and cuts dilution via $379M ...

Warner Bros. Discovery outpaces the S&P 500 with streaming growth, strong financials, and global appeal. Read here for an ...

ULTY offers a 126% yield by targeting volatile sectors for option income, but long-term risks and NAV decline limit appeal.

Discover how to identify the 4% of stocks driving market gains. Focus on winners with growth potential and avoid common ...

Itafos is a top US phosphate fertilizer producer, is poised for growth amid rising demand and prices. It trades at a cheap 4x ...